Morgan Stanley Treace Medical Concepts, Inc. Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TMCI
# of Institutions
129Shares Held
39.4MCall Options Held
272KPut Options Held
261K-
Armistice Capital, LLC New York, NY5.36MShares$25.6 Million0.46% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$19.4 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.68MShares$17.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.62MShares$17.3 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.37MShares$11.3 Million1.59% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $265M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...